Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2001-10-18
Target enrollment:
Participant gender:
Summary
This trial is conducted in Japan. The aim of this trial is to investigate the safety and
efficacy of biphasic insulin aspart (BIAsp) 50 (NN-X14Mix50) compared with biphasic human
insulin (BHI) 50 in subjects with type 2 diabetes.